UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 465

Sortiert nach

Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models

Arteriosclerosis, thrombosis, and vascular biology, 2004-04, Vol.24 (4), p.644

2004

Volltextzugriff (PDF)

Exendin‐4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration

British journal of pharmacology, 2014-02, Vol.171 (3), p.723-734

2014

Volltextzugriff (PDF)

APOE3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome

Diabetes, obesity & metabolism, 2014-06, Vol.16 (6), p.537-544

2014

Volltextzugriff (PDF)

No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E3-leiden/human C-reactive protein transgenic mice

Arteriosclerosis, thrombosis, and vascular biology, 2005-08, Vol.25 (8), p.1635

2005

Volltextzugriff (PDF)

Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3

Arteriosclerosis, thrombosis, and vascular biology, 1999-03, Vol.19 (3), p.472

1999

Volltextzugriff (PDF)

White Adipose Tissue: Getting Nervous

Journal of neuroendocrinology, 2003-11, Vol.15 (11), p.1005-1010

2003

Volltextzugriff (PDF)

effect of dietary phytosphingosine on cholesterol levels and insulin sensitivity in subjects with the metabolic syndrome

European journal of clinical nutrition, 2010-04, Vol.64 (4), p.419-423

2010

Volltextzugriff (PDF)

Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice

Arteriosclerosis, thrombosis, and vascular biology, 2006-12, Vol.26 (12), p.2710

2006

Volltextzugriff (PDF)

The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor

Journal of thrombosis and haemostasis, 2005-06, Vol.3 (6), p.1257-1265

2005

Volltextzugriff (PDF)

Gut-Brain Axis: Regulation of Glucose Metabolism

Journal of neuroendocrinology, 2006-12, Vol.18 (12), p.883-894

2006

Volltextzugriff (PDF)

Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice

Diabetologia, 2005-08, Vol.48 (8), p.1621-1626

2005

Volltextzugriff (PDF)

Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in Gram-negative sepsis

The FASEB journal, 2006-10, Vol.20 (12), p.2162-2164

2006

Volltextzugriff (PDF)

Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis

Arteriosclerosis, thrombosis, and vascular biology, 2000-02, Vol.20 (2), p.290

2000

Volltextzugriff (PDF)

Leptin Deficiency Per Se Dictates Body Composition and Insulin Action in ob/ob Mice

Journal of neuroendocrinology, 2008-01, Vol.20 (1), p.120-127

2008

Volltextzugriff (PDF)

Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice

Diabetologia, 2006-12, Vol.49 (12), p.3049-3057

2006

Volltextzugriff (PDF)

The dual PPARα/γ agonist tesaglitazar blocks progression of pre‐existing atherosclerosis in APOE3Leiden.CETP transgenic mice

British journal of pharmacology, 2009-04, Vol.156 (7), p.1067-1075

2009

Volltextzugriff (PDF)

Apolipoprotein E and carotid artery atherosclerosis: The Rotterdam study

Stroke (1970), 2001-09, Vol.32 (9), p.1947-1952

2001

Volltextzugriff (PDF)

Dietary vegetable oil and wood derived plant stanol esters reduce atherosclerotic lesion size and severity in apoE3-Leiden transgenic mice

Atherosclerosis, 2001-08, Vol.157 (2), p.375-381

2001

Volltextzugriff (PDF)

Accelerated Atherosclerosis by Placement of a Perivascular Cuff and a Cholesterol-Rich Diet in ApoE3Leiden Transgenic Mice

Circulation research, 2000-08, Vol.87 (3), p.248-253

2000

Volltextzugriff (PDF)

Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis

Journal of thrombosis and haemostasis, 2015-01, Vol.13 (1), p.126-135

2015

Volltextzugriff (PDF)

The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the α2-adrenergic receptors in beta cells

Biochemical pharmacology, 2010-06, Vol.79 (12), p.1827-1836

2010

Volltextzugriff (PDF)

Stimulation of Lipogenesis by Pharmacological Activation of the Liver X Receptor Leads to Production of Large, Triglyceride-rich Very Low Density Lipoprotein Particles

The Journal of biological chemistry, 2002-09, Vol.277 (37), p.34182-34190

2002

Volltextzugriff (PDF)

High fat diet induced hepatic insulin resistance is not related to changes in hypothalamic mRNA expression of NPY, AgRP, POMC and CART in mice

Peptides (New York, N.Y. : 1980), 2005-12, Vol.26 (12), p.2554-2558

2005

Volltextzugriff (PDF)

ApoAV Reduces Plasma Triglycerides by Inhibiting Very Low Density Lipoprotein-Triglyceride (VLDL-TG) Production and Stimulating Lipoprotein Lipase-mediated VLDL-TG Hydrolysis

The Journal of biological chemistry, 2004-07, Vol.279 (27), p.27941-27947

2004

Volltextzugriff (PDF)

1 – 25 von 465

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(435)
Mit Volltextzugriff
(390)

Publikationsform

Artikel
(464)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(340)
Life Sciences & Biomedicine
(332)
Humans
(263)
Animals
(199)
Biological And Medical Sciences
(196)
Male
(176)
Mice
(171)
Female
(160)
Medical Sciences
(141)
Apolipoproteins E - Genetics
(116)
Mice, Transgenic
(88)
Cardiovascular System & Cardiology
(84)
Biochemistry & Molecular Biology
(83)
Adult
(77)
Peripheral Vascular Disease
(74)
Middle Aged
(73)
Cholesterol - Blood
(71)
Fundamental And Applied Biological Sciences. Psychology
(69)
Mice, Inbred C57bl
(67)
Atherosclerosis
(61)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models

Exendin‐4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration

APOE3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome

No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E3-leiden/human C-reactive protein transgenic mice

Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3

White Adipose Tissue: Getting Nervous

effect of dietary phytosphingosine on cholesterol levels and insulin sensitivity in subjects with the metabolic syndrome

Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice

Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and Type 2 diabetes susceptibility

The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor

Gut-Brain Axis: Regulation of Glucose Metabolism

Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice

Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in Gram-negative sepsis

Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis

Leptin Deficiency Per Se Dictates Body Composition and Insulin Action in ob/ob Mice

Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice

The dual PPARα/γ agonist tesaglitazar blocks progression of pre‐existing atherosclerosis in APOE3Leiden.CETP transgenic mice

Apolipoprotein E and carotid artery atherosclerosis: The Rotterdam study

Dietary vegetable oil and wood derived plant stanol esters reduce atherosclerotic lesion size and severity in apoE3-Leiden transgenic mice

Accelerated Atherosclerosis by Placement of a Perivascular Cuff and a Cholesterol-Rich Diet in ApoE3Leiden Transgenic Mice

Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis

The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the α2-adrenergic receptors in beta cells

Stimulation of Lipogenesis by Pharmacological Activation of the Liver X Receptor Leads to Production of Large, Triglyceride-rich Very Low Density Lipoprotein Particles

High fat diet induced hepatic insulin resistance is not related to changes in hypothalamic mRNA expression of NPY, AgRP, POMC and CART in mice

ApoAV Reduces Plasma Triglycerides by Inhibiting Very Low Density Lipoprotein-Triglyceride (VLDL-TG) Production and Stimulating Lipoprotein Lipase-mediated VLDL-TG Hydrolysis

Suchergebnisse filtern